RU2020117927A3 - - Google Patents

Download PDF

Info

Publication number
RU2020117927A3
RU2020117927A3 RU2020117927A RU2020117927A RU2020117927A3 RU 2020117927 A3 RU2020117927 A3 RU 2020117927A3 RU 2020117927 A RU2020117927 A RU 2020117927A RU 2020117927 A RU2020117927 A RU 2020117927A RU 2020117927 A3 RU2020117927 A3 RU 2020117927A3
Authority
RU
Russia
Application number
RU2020117927A
Other languages
Russian (ru)
Other versions
RU2020117927A (ru
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/058949 external-priority patent/WO2019090069A1/en
Publication of RU2020117927A publication Critical patent/RU2020117927A/ru
Publication of RU2020117927A3 publication Critical patent/RU2020117927A3/ru

Links

RU2020117927A 2017-11-02 2018-11-02 Модуляторы интегрированного стресса RU2020117927A (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762580726P 2017-11-02 2017-11-02
US62/580,726 2017-11-02
US201862643059P 2018-03-14 2018-03-14
US62/643,059 2018-03-14
PCT/US2018/058949 WO2019090069A1 (en) 2017-11-02 2018-11-02 Modulators of the integrated stress pathway

Publications (2)

Publication Number Publication Date
RU2020117927A RU2020117927A (ru) 2021-12-03
RU2020117927A3 true RU2020117927A3 (cg-RX-API-DMAC7.html) 2022-05-19

Family

ID=64572456

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2020117927A RU2020117927A (ru) 2017-11-02 2018-11-02 Модуляторы интегрированного стресса

Country Status (21)

Country Link
US (2) US20200361941A1 (cg-RX-API-DMAC7.html)
EP (1) EP3704094B1 (cg-RX-API-DMAC7.html)
JP (1) JP7337790B2 (cg-RX-API-DMAC7.html)
KR (1) KR20200096918A (cg-RX-API-DMAC7.html)
CN (1) CN112189008A (cg-RX-API-DMAC7.html)
AU (2) AU2018358346A1 (cg-RX-API-DMAC7.html)
BR (1) BR112020008841A2 (cg-RX-API-DMAC7.html)
CA (1) CA3080801A1 (cg-RX-API-DMAC7.html)
CL (1) CL2020001184A1 (cg-RX-API-DMAC7.html)
CO (1) CO2020006227A2 (cg-RX-API-DMAC7.html)
CR (1) CR20200243A (cg-RX-API-DMAC7.html)
EC (1) ECSP20027553A (cg-RX-API-DMAC7.html)
IL (1) IL274368B2 (cg-RX-API-DMAC7.html)
MX (1) MX2020004551A (cg-RX-API-DMAC7.html)
PE (1) PE20210040A1 (cg-RX-API-DMAC7.html)
PH (1) PH12020550524A1 (cg-RX-API-DMAC7.html)
RU (1) RU2020117927A (cg-RX-API-DMAC7.html)
SG (1) SG11202003985YA (cg-RX-API-DMAC7.html)
TW (1) TWI818929B (cg-RX-API-DMAC7.html)
UY (1) UY37956A (cg-RX-API-DMAC7.html)
WO (1) WO2019090069A1 (cg-RX-API-DMAC7.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3512839A4 (en) 2016-09-18 2020-03-25 H. Lee Moffitt Cancer Center And Research Institute, Inc. AGAINST INTERACTION OF YAP1 WITH YCT1 INHIBITORS
IL301709B2 (en) 2017-08-09 2025-07-01 Denali Therapeutics Inc Compounds, compositions and methods
TW201920129A (zh) 2017-09-01 2019-06-01 美商戴納立製藥公司 化合物、組合物及方法
JP2021501785A (ja) 2017-11-02 2021-01-21 カリコ ライフ サイエンシーズ エルエルシー 統合的ストレス経路の調節剤
JP2021508336A (ja) 2017-12-13 2021-03-04 プラクシス バイオテック エルエルシー 統合的ストレス応答経路の阻害剤
WO2019178401A1 (en) 2018-03-14 2019-09-19 H. Lee Moffitt Cancer Center And Research Institute, Inc. Yap1 inhibitors that target the interaction of yap1 with oct4
US11166942B2 (en) 2018-06-05 2021-11-09 Praxis Biotech LLC Inhibitors of integrated stress response pathway
JP2021529814A (ja) * 2018-07-09 2021-11-04 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited 化学化合物
TW202545902A (zh) * 2018-10-11 2025-12-01 美商嘉來克生命科學有限責任公司 整合應激路徑之前藥調節劑
CR20210426A (es) 2019-02-13 2021-09-30 Denali Therapeutics Inc Compuestos, composiciones y métodos
EP3924341A4 (en) 2019-02-13 2022-11-02 Denali Therapeutics Inc. Compounds, compositions and methods
MX2021012904A (es) 2019-04-23 2022-01-18 Evotec Int Gmbh Moduladores de la via de respuesta al estres integrada.
WO2020216766A1 (en) 2019-04-23 2020-10-29 Evotec International Gmbh Modulators of the integrated stress response pathway
AR118836A1 (es) * 2019-04-30 2021-11-03 Calico Life Sciences Llc Moduladores de la vía de tensión integrada
JP2022536663A (ja) 2019-06-12 2022-08-18 プラクシス バイオテック エルエルシー 統合的ストレス応答経路のモジュレーター
IL291665B2 (en) * 2019-09-27 2025-07-01 Univ Texas Inhibitors of receptor interacting protein kinase i for the treatment of disease
CA3162526A1 (en) 2020-01-28 2021-08-05 Christopher John Brown Modulators of the integrated stress response pathway
KR20220151635A (ko) 2020-03-11 2022-11-15 에보텍 인터내셔널 게엠베하 통합 스트레스 반응 경로의 조절제
WO2021211742A1 (en) * 2020-04-14 2021-10-21 The General Hospital Corporation Use of gcn2 inhibitors in treating mitochondrial myopathies and diseases associated with mitochondrial dysfunction
BR112023003423A2 (pt) * 2020-08-26 2023-03-21 Vertex Pharma Inibidores de apol1 e métodos de uso destes
CA3195290A1 (en) 2020-10-22 2022-04-28 Holly Victoria Atton Modulators of the integrated stress response pathway
MX2023004677A (es) 2020-10-22 2023-05-24 Evotec Int Gmbh Moduladores de la via de respuesta integrada al estres.
ES2997335T3 (en) 2020-10-22 2025-02-17 Evotec Int Gmbh Modulators of the integrated stress response pathway
TW202241857A (zh) 2020-12-18 2022-11-01 美商戴納立製藥公司 化合物之固體形式
CN118146172B (zh) * 2022-12-06 2026-06-19 帕潘纳(北京)科技有限公司 7-氟-6-氨基-2h-1,4-苯并恶嗪-3(4h)-酮的制备方法
CN121263408A (zh) * 2023-07-14 2026-01-02 深圳众格生物科技有限公司 一种化合物、包含其的药物组合物及其用途
KR102992203B1 (ko) * 2024-02-05 2026-07-20 재단법인 대구경북첨단의료산업진흥재단 신규한 eIF2B 작용제 및 이를 포함하는 대사질환 예방 또는 치료용 조성물
US12303604B1 (en) 2024-10-16 2025-05-20 Currax Pharmaceuticals Llc Pharmaceutical formulations comprising naltrexone and/or bupropion

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1026506A (en) * 1962-10-17 1966-04-20 Du Pont Bicyclodiamines and preparation thereof
US3264351A (en) * 1964-07-08 1966-08-02 American Home Prod 1, 4-diaminobicyclo [2.2.2] octanes
US3301827A (en) * 1965-05-07 1967-01-31 Du Pont Polymers from polycyclic reactants having functional substituents on bridgehead carbon atoms
US4911920A (en) 1986-07-30 1990-03-27 Alcon Laboratories, Inc. Sustained release, comfort formulation for glaucoma therapy
FR2588189B1 (fr) 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
DK0495421T3 (da) 1991-01-15 1996-12-09 Alcon Lab Inc Anvendelse af carragenaner i topiske ophthalmiske sammensætninger
US5212162A (en) 1991-03-27 1993-05-18 Alcon Laboratories, Inc. Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
TWI538905B (zh) * 2010-12-22 2016-06-21 H 朗德貝克公司 雙環[3.2.1]辛基醯胺衍生物及其用途
WO2014144952A2 (en) * 2013-03-15 2014-09-18 Peter Walter Modulators of the eif2alpha pathway
WO2015038778A1 (en) * 2013-09-11 2015-03-19 The Brigham And Women's Hospital, Inc. SUBSTITUTED UREA EIF2α KINASE ACTIVATORS
TWI920577B (zh) * 2016-05-05 2026-04-01 美商嘉來克生命科學有限責任公司 整合應激途徑之調節劑
TW201808903A (zh) * 2016-05-05 2018-03-16 嘉來克生命科學有限責任公司 整合應激途徑之調節劑
TW201808888A (zh) * 2016-05-05 2018-03-16 嘉來克生命科學有限責任公司 整合應激途徑之調節劑
CN106349130B (zh) * 2016-08-25 2018-01-23 潍坊大有生物化工有限公司 一种新的氟苯尼考的合成方法

Similar Documents

Publication Publication Date Title
BR102023005164A2 (cg-RX-API-DMAC7.html)
BR102022025291A2 (cg-RX-API-DMAC7.html)
BR102022017795A2 (cg-RX-API-DMAC7.html)
BR112025024041B1 (pt) Elemento de despejamento para uma embalagem compósita e embalagem compósita com um elemento de despejamento
BR112025008516B1 (pt) Método tudo em um de recuperação de níquel para recuperar níquel a partir de matérias-primas contendo níquel
BR112025016688B1 (pt) Compostos e composições farmacêuticas
BR112025011041B1 (pt) Dispositivo para inspeção de um elemento roscado e método de inspeção correspondente
BR112024022558B1 (pt) Polipeptídeo, polinucleotídeo, ácido nucleico, vetor, célula hospedeira, método para produzir o polipeptídeo, composição, e, método in vitro para aumentar adesão celular
BR112025005915B1 (pt) Gerador, dispositivo e método de ablação de campo pulsado
BR102023016405B1 (pt) Estrutura de viga de pá, pá de energia eólica e equipamento de energia eólica
BR112024026850B1 (pt) Triturador de mandíbula e método de serviço ou de manutenção de um triturador de mandíbula
BR112024025233B1 (pt) Método para alterar o estado de elevação vertical para um veículo transportador, controle e veículo
BR102023009702B1 (pt) Dispositivo para alisamento e aplicação de substância de tratamento
BR112024027500B1 (pt) Polipeptídeo, ácido nucleico, vetor, célula hospedeira, método para produzir o polipeptídeo, composição, uso do polipeptídeo, e, método para promover a proliferação de uma célula in vitro
BR112024018530B1 (pt) Método para determinar nível de escória do alto-forno, método para operar alto-forno e unidade de controle
BR112024027130B1 (pt) Sistema e método para um conjunto de cuff (balão) de tubo endotraqueal
BR112025001284B1 (pt) Cabo, sistema de sensor e método de montagem de um alojamento de sensor
BR102022026432B1 (pt) Dispositivo de transferência de esforços transversais em juntas de dilatação
BR102022024748B1 (pt) Equipamento extrator de esporos da superfície de grãos de cereal para aplicação em laboratório e seu processo operacional
BR102022023712B1 (pt) Sistema de montagem de estrutura flexível para estufas agrícolas, com sistema molejante de movimentação em relação à ação dos ventos
BR122025008970A2 (pt) Método para decodificar um vídeo, sistema e mídia legível por computador
BR122025008972A2 (pt) Sistema, método para decodificar um vídeo e mídia legível por computador
BR122025008973A2 (pt) Sistema, método para decodificar um vídeo e mídia legível por computador
BR102022012728B1 (pt) Unidade para visualização do reinício de escoamento de fluidos dependentes do tempo
BR102022009310B1 (pt) Sistema de montagem para as linhas de adubo de implementos agrícolas